Title:
KERATIN BD-1, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/083190
Kind Code:
A1
Abstract:
Provided is a keratin BD-1, a nucleic acid molecule encoding the keratin BD-1, an expression vector containing the nucleic acid molecule, a host cell containing the expression vector or genome integrating the nucleic acid molecule, and a preparation method for the keratin BD-1, a pharmaceutical composition containing the keratin BD-1, and a use for the keratin BD-1, the nucleic acid molecule, the expression vector, the host cell, or the pharmaceutical composition in the preparation of antipyretic and analgesic, antitussive and phlegm-dispelling, anticonvulsant, antiepileptic, blood pressure reducing, anti-inflammatory, and antiviral drugs.
More Like This:
| JP2013512251 | Simultaneous inhibition of PD-L1 / PD-L2 |
| WO/2003/056027 | CARBOHYDRATE-ASSOCIATED PROTEINS |
| JP2011087587 | 21 HUMAN SECRETED PROTEINS |
Inventors:
YU SHISHAN (CN)
WANG XIAOLIANG (CN)
QU JING (CN)
SHI GUORU (CN)
FU JIANG (CN)
WANG LING (CN)
FENG NAN (CN)
XU SHAOFENG (CN)
WANG XIAOLIANG (CN)
QU JING (CN)
SHI GUORU (CN)
FU JIANG (CN)
WANG LING (CN)
FENG NAN (CN)
XU SHAOFENG (CN)
Application Number:
PCT/CN2020/124325
Publication Date:
May 06, 2021
Filing Date:
October 28, 2020
Export Citation:
Assignee:
INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCICENCES (CN)
International Classes:
C07K14/47; A61K38/17; A61P9/12; A61P11/00; A61P25/08; A61P29/00; A61P31/12; C12N15/12; C12N15/63
Domestic Patent References:
| WO2008130607A2 | 2008-10-30 |
Foreign References:
| CN101647814A | 2010-02-17 | |||
| CN107519203A | 2017-12-29 | |||
| CN102993291A | 2013-03-27 |
Other References:
DATABASE Nucleotide 25-06-2020, ANONYMOUS: "Bos taurus keratin 31 (KRT31), mRNA", XP055806890, retrieved from NCBI Database accession no. NM_001076506
See also references of EP 4053151A4
See also references of EP 4053151A4
Download PDF: